Literature DB >> 16547237

Induction of peripheral T cell tolerance by antigen-presenting B cells. II. Chronic antigen presentation overrules antigen-presenting B cell activation.

Giorgio Raimondi1, Ivan Zanoni, Stefania Citterio, Paola Ricciardi-Castagnoli, Francesca Granucci.   

Abstract

Ag presentation in the absence of danger signals and Ag persistence are the inductive processes of peripheral T cell tolerization proposed so far. Nevertheless, it has never been definitively shown that chronic Ag presentation per se can induce T cell tolerance independent of the state of activation of APCs. In the present work, we investigated whether chronic Ag presentation by either resting or activated B cells can induce tolerance of peripheral Ag-specific T cells. We show that CD4(+) T cells that re-encounter the Ag for a prolonged period, presented either by resting or activated Ag-presenting B cells, become nonfunctional and lose any autoimmune reactivity. Thus, when the main APCs are B cells, the major mechanism responsible for peripheral T cell tolerization is persistent Ag exposure, independent of the B cell activation state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547237     DOI: 10.4049/jimmunol.176.7.4021

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

2.  Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Authors:  Giorgio Raimondi; Tina L Sumpter; Benjamin M Matta; Mahesh Pillai; Natasha Corbitt; Yoram Vodovotz; Zhiliang Wang; Angus W Thomson
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 3.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

4.  Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function.

Authors:  Ping-Ying Pan; George X Wang; Bingjiao Yin; Junko Ozao; Teresa Ku; Celia M Divino; Shu-Hsia Chen
Journal:  Blood       Date:  2007-09-20       Impact factor: 22.113

5.  In situ vaccine, immunological memory and cancer cure.

Authors:  Kangla Tsung; Jeffrey A Norton
Journal:  Hum Vaccin Immunother       Date:  2015-09-11       Impact factor: 3.452

6.  Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation.

Authors:  Mark S Wilson; Matthew D Taylor; Mary T O'Gorman; Adam Balic; Tom A Barr; Kara Filbey; Stephen M Anderton; Rick M Maizels
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

7.  CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells.

Authors:  Mélissa Mathieu; Natacha Cotta-Grand; Jean-François Daudelin; Salix Boulet; Réjean Lapointe; Nathalie Labrecque
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

8.  Characterization of c-Maf+Foxp3- Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells.

Authors:  Chien-Hui Chien; Hui-Chieh Yu; Szu-Ying Chen; Bor-Luen Chiang
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

Review 9.  Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells.

Authors:  Chien-Hui Chien; Bor-Luen Chiang
Journal:  J Biomed Sci       Date:  2017-11-18       Impact factor: 8.410

Review 10.  Tumor reductive therapies and antitumor immunity.

Authors:  Huiqin Guo; Kangla Tsung
Journal:  Oncotarget       Date:  2017-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.